Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Gastroenterology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Crohn's Disease Clinical Trials

A listing of Crohn's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (6) clinical trials

Researchers at the University of Kentucky are inviting you to participate as a healthy individual in a study to determine whether an acute, acquired infection is associated with onset Crohn’s disease. This study will require one visit to the University of Kentucky. You will receive a $10 gift card for ...

Phase N/A

Researchers at the University of Kentucky are inviting you to participate as a healthy individual in a study to determine whether an acute, acquired infection is associated with onset Crohn’s disease. This study will require one visit to the University of Kentucky. You will receive a $10 gift card for ...

Phase N/A

A research study is evaluating an investigational medication for the possible treatment of moderate to severely active Crohn’s disease.  

Phase N/A

QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's Disease

The QBECO-CD-02 trial in subjects with moderate to severe Crohn's disease (CD) is intended to build on past experience with QBECO SSI and further establish the safety and efficacy of QBECO SSI for the induction of clinical and/or endoscopic response and remission. i. Overall Design: Phase II, randomized, double-blind, placebo-controlled ...

Phase

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn s Disease

The effectiveness and safety of induction and maintenance therapy of Ustekinumab and other biologics will be assessed in different relevant subgroups of Crohn`s Disease patients. To this end, different confounders have to be considered. Patients followed-up for several years will likely receive changing treatments. These changes have to be taken ...

Phase N/A

Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease

The main purpose of this study is to assess ustekinumab's ability to induce clinical response and remission ("effectiveness") at Week 16 and remission at Week 52 and Week 104 in participants with Crohn's disease (CD). Response and remission will be assessed using clinical parameters. Retention rate at week 52 and ...

Phase N/A